Philips is recognized for its cutting-edge innovation and comprehensive digital pathology ecosystem, which is driving the global transformation of diagnostics and health IT.
SAN ANTONIO, January 30, 2026 /PRNewswire/ — Frost and Sullivan is pleased to announce that Philips received the 2025 Global Recognition for Enabling Technology Leadership in Digital Pathology and Health IT for its outstanding achievements in next-generation digital pathology innovation, accelerated workflow modernization, and clinical informatics. This recognition highlights Philips Healthcare’s continued leadership in achieving measurable results, strengthening its global market presence and delivering customer-centric innovations in an increasingly complex healthcare environment.
Frost & Sullivan evaluates companies using a rigorous benchmarking process focusing on two primary dimensions: effectiveness and strategy execution. Philips Healthcare excels in both areas, demonstrating its ability to align its long-term innovation strategy with global market demand while executing at scale with consistency and precision. “Philips leads the global healthcare industry in terms of patent applications. This propensity for innovation has positioned the company at the forefront of one of the most dynamic areas in the sector: digital pathology. Building on this heritage, Philips Healthcare has become a global leader in digital pathology,” said Melissa Kenig, principal consultant at Frost & Sullivan.
Guided by a long-term growth strategy focused on digital innovation, customer partnerships and scalable enterprise IT, Philips has demonstrated strong adaptability and leadership in a rapidly evolving diagnostics ecosystem. The company’s sustained investments in digital pathology and AI1.2 informatics has enabled him to provide value in diverse clinical environments, from large academic medical centers to multi-site laboratory networks.
Innovation remains fundamental to Philips Healthcare’s approach. Its integrated digital pathology portfolio, including high-performance slide scanners, robust image management system, advanced AI-based technologies2 workflows, cloud archiving by Cloud Data Services3and comprehensive laboratory workflow support, meet the end-to-end needs of modern pathology practices. These capabilities are enhanced by the Philips IntelliSite Pathology solution, the first digital pathology platform to receive FDA 510(k) clearance for primary diagnostics.
“As demand for diagnostics increases and resources become tighter, digital pathology is becoming fundamental to modern care. Frost & Sullivan’s recognition underscores our commitment to transforming innovation into meaningful impact by streamlining workflows, enabling collaboration and accelerating diagnosis, while responsibly advancing AI to support better patient care,” said Martijn Hartjes, Head of Clinical IT Business Unit at Philips.
Philips’ commitment to customer experience further amplifies its global leadership. With more than 3,500 pathologists in more than 40 countries using the Philips digital pathology platform and more than 38 million slides scanned worldwide, the company has built one of the largest and most clinically validated installed bases in the industry. Its structured implementation services, extensive training programs and globally unified support organization ensure strong customer engagement, high system availability and seamless scalability across enterprise networks.
Frost & Sullivan applauds Philips for setting the industry benchmark for competitive strategy, technology innovation and global execution. Philips’ vision for an open, interoperable, AI-driven environment2 digital diagnostics is shaping the future of digital pathology and redefining what’s possible for healthcare organizations seeking to improve the accuracy, speed and collaboration of diagnostics at scale.
Each year, Frost & Sullivan presents the Enabling Technology Leadership Recognition Award to a company that demonstrates exceptional strategy development and implementation, resulting in measurable improvements in market share, customer satisfaction and competitive positioning. This recognition honors organizations that are transforming their industries through forward-thinking innovation and growth excellence.
|
1 PIPS enables iSyntax files, and with the SDK, third-party companies can use it for AI capabilities. |
Frost & Sullivan Best Practices Recognition
Frost & Sullivan Best Practices recognitions recognize companies in regional and global markets that demonstrate exceptional achievement and consistent excellence in areas such as leadership, technology innovation, customer experience and strategic product development. Each recognition is the result of a rigorous analytical process in which Frost & Sullivan industry experts evaluate performance through comprehensive interviews, in-depth analysis and extensive secondary research. The goal is to identify the best organizations that are driving transformative growth and setting new industry standards.
Contact us: start the discussion.
Contact:
Ashley Shreve
E : ashley.weinkauf@frost.com
About Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and human-centered innovation leverages cutting-edge technology and deep clinical and consumer insights to deliver personal health solutions to consumers and professional health solutions to healthcare providers and their patients in hospitals and at home.
Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise IT, as well as personal health. Philips generated revenue of €18 billion in 2024 and employs approximately 67,300 people with sales and services in more than 100 countries. Philips news can be found at www.philips.com/newscenter.
SOURCE Gros & Sullivan
